Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
Colorcon
Dow
Mallinckrodt
Merck

Last Updated: October 21, 2019

DrugPatentWatch Database Preview

Details for Patent: 6,739,333

See Plans and Pricing

« Back to Dashboard

Which drugs does patent 6,739,333 protect, and when does it expire?

Patent 6,739,333 protects ATROVENT HFA and is included in one NDA.

This patent has fifty patent family members in thirty-eight countries.

Summary for Patent: 6,739,333
Title: Stainless steel canister for propellant-driven metering aerosols
Abstract:The present invention relates to corrosion resistant stainless steel canisters for propellant-containing aerosol forumlations for use in propellant gas-operated inhalers.
Inventor(s): Hoelz; Hubert (Oberheimbach, DE), Lostritto; Richard Thomas (Gaithersburg, MD), Nagel; Juergen (Bad Kreuznach, DE), Vega; Julio Cesar (Buenos Aires, AR)
Assignee: Boehringer Ingelheim Pharma KG (Ingelheim, DE)
Application Number:09/580,246
Patent Claim Types:
see list of patent claims
Delivery; Device; Formulation;

Drugs Protected by US Patent 6,739,333

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Boehringer Ingelheim ATROVENT HFA ipratropium bromide AEROSOL, METERED;INHALATION 021527-001 Nov 27, 2004 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,739,333

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany199 24 098May 26, 1999

International Family Members for US Patent 6,739,333

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 024113   Start Trial
Austria 289276   Start Trial
Australia 5809200   Start Trial
Australia 772768   Start Trial
Bulgaria 106108   Start Trial
Bulgaria 64861   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
AstraZeneca
Moodys
Harvard Business School
Boehringer Ingelheim
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.